company

DOKKA BIOVARME AS

2870 DOKKA

Return on Equity
14,71 %
Current Ratio
2,43
Debt-to-Equity Ratio
0,08
Key figures (NOK)2022
Revenue3 358 000
Net Income842 000
Total Assets7 960 000
Total Equity5 725 000
Income (NOK)2022
Revenue3 358 000
Expenditure2 271 000
Operating Profit1 058 000
Financial Income40 000
Financial Costs26 000
Financial Balance14 000
Earnings Before Tax1 072 000
Tax230 000
Net Income842 000
Balance (NOK)2022
Total Fixed Assets3 588 000
Total Current Assets4 372 000
Total Assets7 960 000
Total Retained Equity4 711 000
Total Equity5 725 000
Total Long-Term Debt436 000
Total Current Debt1 799 000
Total Equity and Debt7 960 000
Cash flow (NOK)2022
Sales Income3 358 000
Other Income0
Revenue3 358 000
Cost of Goods Sold1 686 000
Salary Costs11 000
Depreciation166 000
Impairment0
Expenditure2 271 000
Operating Profit1 058 000
Financial Income40 000
Financial Costs26 000
Financial Balance14 000
Dividends225 000
Net Income842 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate930 000
Machinery and Plant Facilities852 000
Fixtures0
Total Tangible Assets1 781 000
Total Fiancial Fixed Assets1 807 000
Total Fixed Assets3 588 000
Stock1 042 000
Total Investments0
Cash, Bank2 013 000
Total Current Assets4 372 000
Total Assets7 960 000
Total Equity5 725 000
Short-Term Group Debt0
Total Long-Term Debt436 000
Creditors927 000
Unpaid Taxes360 000
Dividends225 000
Other Current Debt30 000
Total Current Debt1 799 000
Total Equity and Debt7 960 000
Financial indicators2022
Return on Equity14,71 %
Debt-to-Equity Ratio0,08
Operating Profit Margin31,51 %
Current Ratio2,43
Quick Ratio5,78
Equity Ratio0,72
Gross Profit Margin49,79 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English